Guardant Health (GH) PT Raised to $160 at BTIG, Second Day in a Row
Tweet Send to a Friend
BTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $160.00 (from $155.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
